Published in Ann Neurol on March 17, 2011
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol (2012) 4.36
Testing the right target and right drug at the right stage. Sci Transl Med (2011) 3.55
Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol (2011) 2.83
Brain β-amyloid load approaches a plateau. Neurology (2013) 2.50
Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol (2015) 2.18
Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol (2014) 2.13
Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals. J Neurosci (2013) 2.01
The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93
Brain amyloid and cognition in Lewy body diseases. Mov Disord (2012) 1.87
Resting state functional connectivity in preclinical Alzheimer's disease. Biol Psychiatry (2013) 1.86
The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol (2011) 1.79
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement (2013) 1.77
Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia (2011) 1.60
Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease. AJNR Am J Neuroradiol (2012) 1.57
Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron (2013) 1.54
Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol (2012) 1.44
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging (2012) 1.43
Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. J Neurosci (2011) 1.41
The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron (2014) 1.35
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology (2012) 1.33
What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Prog Neurobiol (2014) 1.29
Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol (2013) 1.29
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex (2011) 1.26
The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. Cereb Cortex (2011) 1.23
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. Neuroimage Clin (2013) 1.21
Tau imaging in neurodegenerative diseases. Eur J Nucl Med Mol Imaging (2015) 1.21
Accelerating cortical thinning: unique to dementia or universal in aging? Cereb Cortex (2012) 1.20
Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Hum Brain Mapp (2012) 1.17
Toward a multifactorial model of Alzheimer disease. Neurobiol Aging (2012) 1.16
Failure to modulate attentional control in advanced aging linked to white matter pathology. Cereb Cortex (2011) 1.12
Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia. Neurology (2013) 1.11
The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition. Neuroimage (2013) 1.05
Multiple Brain Markers are Linked to Age-Related Variation in Cognition. Cereb Cortex (2014) 1.02
Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease. Neuroimage Clin (2013) 1.02
Instrumental activities of daily living impairment is associated with increased amyloid burden. Dement Geriatr Cogn Disord (2011) 1.01
Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults. J Neurosci (2014) 1.00
In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain. J Neurosci (2016) 1.00
In vivo characterization of the early states of the amyloid-beta network. Brain (2013) 0.99
The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement (2013) 0.98
Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging. Aging Dis (2011) 0.97
Imaging biomarkers associated with cognitive decline: a review. Biol Psychiatry (2014) 0.94
Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers. J Neurol Neurosurg Psychiatry (2012) 0.93
Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. J Alzheimers Dis (2015) 0.93
Enrichment and stratification for predementia Alzheimer disease clinical trials. PLoS One (2012) 0.93
Emerging β-amyloid pathology and accelerated cortical atrophy. JAMA Neurol (2014) 0.93
Odor identification and Alzheimer disease biomarkers in clinically normal elderly. Neurology (2015) 0.92
Association of gray matter atrophy with age, β-amyloid, and cognition in aging. Cereb Cortex (2013) 0.91
Session II: Mechanisms of age-related cognitive change and targets for intervention: neural circuits, networks, and plasticity. J Gerontol A Biol Sci Med Sci (2012) 0.90
CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade. Brain Imaging Behav (2012) 0.90
Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults. J Alzheimers Dis (2015) 0.90
Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. Ann Neurol (2017) 0.89
Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects? Neuroimage Clin (2013) 0.89
Is amyloid-β harmful to the brain? Insights from human imaging studies. Brain (2015) 0.88
Cortical thickness mediates the effect of β-amyloid on episodic memory. Neurology (2014) 0.88
PET amyloid-beta imaging in preclinical Alzheimer's disease. Biochim Biophys Acta (2011) 0.87
Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease. Alzheimers Dement (2014) 0.87
Neuropathological approaches to cerebral aging and neuroplasticity. Dialogues Clin Neurosci (2013) 0.87
Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease. Neurobiol Aging (2013) 0.86
Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease. PLoS One (2014) 0.86
Should we disclose amyloid imaging results to cognitively normal individuals? Neurodegener Dis Manag (2013) 0.86
Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. Neuroimage (2013) 0.86
The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations. Neuropsychol Rev (2014) 0.86
Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals. BMC Med (2012) 0.85
Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine. BMC Med (2013) 0.85
Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects. Alzheimers Dement (2014) 0.84
Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging (2014) 0.83
Structural brain alterations before mild cognitive impairment in ADNI: validation of volume loss in a predefined antero-temporal region. J Alzheimers Dis (2012) 0.83
Apathy is associated with increased amyloid burden in mild cognitive impairment. J Neuropsychiatry Clin Neurosci (2013) 0.83
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2012) 0.83
Current status and future perspectives of magnetic resonance high-field imaging: a summary. Neuroimaging Clin N Am (2012) 0.83
Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study. Alzheimers Res Ther (2014) 0.82
Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease. Alzheimers Dement (2014) 0.82
Multimodal MRI-based Imputation of the Aβ+ in Early Mild Cognitive Impairment. Ann Clin Transl Neurol (2014) 0.81
Neuroimaging predictors of brain amyloidosis in mild cognitive impairment. Ann Neurol (2013) 0.81
Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? Cereb Cortex (2013) 0.81
Structural imaging in early pre-states of dementia. Biochim Biophys Acta (2011) 0.81
Aβ-related hyperactivation in frontoparietal control regions in cognitively normal elderly. Neurobiol Aging (2015) 0.80
PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies. Neurodegener Dis (2015) 0.80
Spatial Navigation in Preclinical Alzheimer's Disease. J Alzheimers Dis (2016) 0.80
Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals. J Neuropsychiatry Clin Neurosci (2014) 0.80
Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough. Imaging Med (2012) 0.79
Brain imaging of neurovascular dysfunction in Alzheimer's disease. Acta Neuropathol (2016) 0.79
Paradigm shift in translational neuroimaging of CNS disorders. Biochem Pharmacol (2011) 0.79
Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. Alzheimers Dement (Amst) (2015) 0.79
Brain structure and function as mediators of the effects of amyloid on memory. Neurology (2015) 0.79
"Is dopamine involved in Alzheimer's disease?". Front Aging Neurosci (2014) 0.79
Biomarkers in Alzheimer's disease. Front Neurol (2011) 0.79
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases. JAMA Neurol (2016) 0.79
Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers. Neurology (2015) 0.78
Responses of the Human Brain to Mild Dehydration and Rehydration Explored In Vivo by 1H-MR Imaging and Spectroscopy. AJNR Am J Neuroradiol (2015) 0.78
Cluster-based statistics for brain connectivity in correlation with behavioral measures. PLoS One (2013) 0.78
The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis. Neurobiol Aging (2017) 0.78
Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease. JAMA Neurol (2017) 0.77
Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring. Neurobiol Aging (2015) 0.77
Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers. J Alzheimers Dis (2015) 0.77
Cortical thickness in relation to clinical symptom onset in preclinical AD. Neuroimage Clin (2016) 0.77
Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression. Neural Plast (2015) 0.77
β-Amyloid Deposition Is Associated with Decreased Right Prefrontal Activation during Task Switching among Cognitively Normal Elderly. J Neurosci (2016) 0.77
Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults. JAMA Psychiatry (2016) 0.76
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A (2000) 19.87
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Automatically parcellating the human cerebral cortex. Cereb Cortex (2004) 18.32
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med (2008) 17.09
Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc Natl Acad Sci U S A (2001) 14.86
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci (2005) 12.85
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci (2009) 12.05
Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol (1999) 10.45
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64
A beta oligomers - a decade of discovery. J Neurochem (2007) 8.88
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50
Thinning of the cerebral cortex in aging. Cereb Cortex (2004) 8.31
Disruption of large-scale brain systems in advanced aging. Neuron (2007) 8.12
Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging (1997) 7.54
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci (1996) 7.19
Parietal lobe contributions to episodic memory retrieval. Trends Cogn Sci (2005) 7.04
Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain (2007) 6.39
Age, neuropathology, and dementia. N Engl J Med (2009) 6.36
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol (2010) 6.17
Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci U S A (2003) 5.64
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex (1992) 5.57
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain (2006) 5.42
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex (2008) 5.36
Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol (1988) 5.18
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol (2010) 5.03
MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology (1992) 4.87
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch Neurol (2009) 4.55
Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology (1992) 4.52
Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci (2009) 4.50
Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage (2007) 4.41
Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology (1997) 4.35
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A (2002) 4.07
Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology (2004) 4.00
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry (2009) 3.72
Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol (2010) 3.64
Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol (2009) 3.60
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol (2010) 3.46
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol (2004) 3.39
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology (2007) 3.24
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
When less means more: deactivations during encoding that predict subsequent memory. Neuroimage (2004) 3.06
Validating cluster size inference: random field and permutation methods. Neuroimage (2003) 3.03
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology (2010) 2.92
The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology (2008) 2.91
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain (2007) 2.88
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain (2007) 2.72
Cytology and functionally correlated circuits of human posterior cingulate areas. Neuroimage (2005) 2.67
Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain (2009) 2.61
Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex (2004) 2.36
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol (2008) 2.19
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain (2009) 2.05
Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology (2010) 1.99
Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage. Neuroimage (2008) 1.98
Brain atrophy in healthy aging is related to CSF levels of Aβ1-42. Cereb Cortex (2010) 1.79
Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet (1999) 1.68
The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies. Neurobiol Aging (1997) 1.57
Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol (2009) 1.42
Education modifies the association of amyloid but not tangles with cognitive function. Neurology (2005) 1.42
Neuronal loss and beta-amyloid removal in the amygdala of people with Down syndrome. Neurobiol Aging (2000) 0.80
Quantitative assessment of ALZ-50 immunoreactivity in Alzheimer's disease. J Geriatr Psychiatry Neurol (1992) 0.77
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci (2009) 12.05
The influence of head motion on intrinsic functional connectivity MRI. Neuroimage (2011) 10.49
Intrinsic functional connectivity as a tool for human connectomics: theory, properties, and optimization. J Neurophysiol (2009) 9.94
Coherent spontaneous activity identifies a hippocampal-parietal memory network. J Neurophysiol (2006) 9.65
The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol (2011) 8.79
Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage (2005) 8.50
Thinning of the cerebral cortex in aging. Cereb Cortex (2004) 8.31
Disruption of large-scale brain systems in advanced aging. Neuron (2007) 8.12
The Extensible Neuroimaging Archive Toolkit: an informatics platform for managing, exploring, and sharing neuroimaging data. Neuroinformatics (2007) 7.97
Functional-anatomic fractionation of the brain's default network. Neuron (2010) 7.48
Open Access Series of Imaging Studies (OASIS): cross-sectional MRI data in young, middle aged, nondemented, and demented older adults. J Cogn Neurosci (2007) 7.31
Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage (2006) 7.14
Evidence for a frontoparietal control system revealed by intrinsic functional connectivity. J Neurophysiol (2008) 7.12
Parietal lobe contributions to episodic memory retrieval. Trends Cogn Sci (2005) 7.04
Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 6.84
A generative model for image segmentation based on label fusion. IEEE Trans Med Imaging (2010) 6.28
Accurate and robust brain image alignment using boundary-based registration. Neuroimage (2009) 6.27
Remembering the past to imagine the future: the prospective brain. Nat Rev Neurosci (2007) 5.86
Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci U S A (2003) 5.64
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex (2008) 5.36
Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage (2012) 5.11
Models of visuospatial and verbal memory across the adult life span. Psychol Aging (2002) 5.03
Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol (2004) 4.89
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. Neuroimage (2010) 4.55
Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci (2009) 4.50
Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging (2007) 4.18
Meditation experience is associated with increased cortical thickness. Neuroreport (2005) 4.15
Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci (2006) 4.14
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
The minimal preprocessing pipelines for the Human Connectome Project. Neuroimage (2013) 4.01
Highly accurate inverse consistent registration: a robust approach. Neuroimage (2010) 3.98
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex (2009) 3.90
Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. Cereb Cortex (2004) 3.87
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol (2007) 3.83
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol (2010) 3.64
Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol Aging (2005) 3.63
Brain morphometry with multiecho MPRAGE. Neuroimage (2008) 3.61
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol (2012) 3.48
Episodic simulation of future events: concepts, data, and applications. Ann N Y Acad Sci (2008) 3.48
Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol (2008) 3.41
Segregated fronto-cerebellar circuits revealed by intrinsic functional connectivity. Cereb Cortex (2009) 3.35
Distinct cortical anatomy linked to subregions of the medial temporal lobe revealed by intrinsic functional connectivity. J Neurophysiol (2008) 3.33
Under-recruitment and nonselective recruitment: dissociable neural mechanisms associated with aging. Neuron (2002) 3.18
Functional-anatomic correlates of memory retrieval that suggest nontraditional processing roles for multiple distinct regions within posterior parietal cortex. J Neurosci (2004) 2.91
Functional-anatomic correlates of remembering and knowing. Neuroimage (2004) 2.89
High consistency of regional cortical thinning in aging across multiple samples. Cereb Cortex (2009) 2.88
The feasibility of a common stereotactic space for children and adults in fMRI studies of development. Neuroimage (2002) 2.87
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol (2011) 2.81
Mixed blocked/event-related designs separate transient and sustained activity in fMRI. Neuroimage (2003) 2.80
Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proc Natl Acad Sci U S A (2005) 2.78
A role for the human dorsal anterior cingulate cortex in fear expression. Biol Psychiatry (2007) 2.78
Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med (2010) 2.77
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol (2012) 2.75
Spherical demons: fast diffeomorphic landmark-free surface registration. IEEE Trans Med Imaging (2009) 2.74
Focal thinning of the cerebral cortex in multiple sclerosis. Brain (2003) 2.74
Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus (2009) 2.66
Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc Natl Acad Sci U S A (2008) 2.65
Test-retest and between-site reliability in a multicenter fMRI study. Hum Brain Mapp (2008) 2.63
On-line automatic slice positioning for brain MR imaging. Neuroimage (2005) 2.62
Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain (2009) 2.61
Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol (2012) 2.61
Aging and the neural correlates of successful picture encoding: frontal activations compensate for decreased medial-temporal activity. J Cogn Neurosci (2005) 2.52
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci (2013) 2.51
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther (2011) 2.51
Common prefrontal regions coactivate with dissociable posterior regions during controlled semantic and phonological tasks. Neuron (2002) 2.44
The A4 study: stopping AD before symptoms begin? Sci Transl Med (2014) 2.43